TPH-104

N/A

Report date: 2025/01/26 15:37:59
NME

Base Information

Drug NameTPH-104
Drug Alias NameRIPK1-selective activator (University of Toledo)thienopyrimidine analog (University of Toledo)TPH-104
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionReceptor-interacting serine/threonine-protein kinase 1 stimulants
TargetsReceptor-interacting serine/threonine-protein kinase 1
Therapy Area/IndicationsTriple Negative Breast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Toledo
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Toledo
Inactive CompaniesN/A
Active IndicationsTriple Negative Breast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A